Bolt Biotherapeutics Inc (NAS:BOLT)
$ 0.626 -0.0039 (-0.62%) Market Cap: 23.96 Mil Enterprise Value: -11.66 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 40/100

Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 07:30PM GMT
Release Date Price: $16.25 (-2.58%)
Matthew Harrison
Morgan Stanley - Analyst

Great. Good afternoon, everybody, and thanks for joining us for the next session. I am Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. Very pleased to have Bolt Bio with us for the next session. Before we get started, I just need to read a quick disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/research disclosures. And to kick us off, I'm going to turn it over to Randy Schatzman, who is the CEO of Bolt and let him make some opening comments and then we can jump right into it.

Randy Schatzman
Bolt Biotherapeutics, Inc. - CEO

Thanks, Matthew, and thanks to the team at Morgan Stanley for including us in what's been a really constructive meeting for us today. I'm joined by Willie Quinn, who is our Chief Financial Officer. And obviously we'll both be answering your questions as you take us through after my opening remarks here.

So just for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot